PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 59 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,009,000 | -57.6% | 150,787 | -53.2% | 0.20% | -69.4% |
| Q3 2020 | $11,811,000 | +11.4% | 322,098 | 0.0% | 0.64% | -1.7% |
| Q2 2020 | $10,600,000 | -39.3% | 322,098 | -52.4% | 0.65% | -59.8% |
| Q1 2020 | $17,469,000 | -28.6% | 676,561 | -13.9% | 1.63% | -12.2% |
| Q4 2019 | $24,471,000 | – | 785,851 | – | 1.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |